Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sernova Corp T.SVA

Alternate Symbol(s):  SEOVF

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.


TSX:SVA - Post by User

Bullboard Posts
Comment by RichyRich$on Feb 15, 2014 12:17am
216 Views
Post# 22213288

RE:Kinda SLEAZY richyrich......

RE:Kinda SLEAZY richyrich......I think Sernova will be the solution over the next 5 to 10 years.  But the future of science is headed toward genetic mapping and reingineering.  Eg, the cure for cancer they're working on reingineers the T-Cells to attack cancer cells throughout the body.  The further future will not require a physical pouch, rather reingeener the islet cells to be disguised for non-attack and T-Cell acceptance.  But that will take a while.  The Cell Pouch will be a bridge technology until then.  And there's nothing wrong with that.  Sernvoa should spike a lot.  However, I'm looking at this from the angle of a stock trader and business man as well.  Shamool understands, I believe he mentioned he swung SVA a few times successfully.  Sernova seems to move like a real non-penny stock company, which usually pull back after a big spike.  Sernova's stock movement usually pulls back.  That was quite the jump and spike rush to double in 5 days!  I need to savour the money for one weekend!  Keep in mind I need the money to pay for this procedure :).  I'll buy her back at $.18.  There are tons of ways to make money.  Junior mining EFT doubled from November to January. But they tend to plateau after doubling.  Bio-med have the best potential and could hit 5 X's growth very fast.  I'm willing to take the risk to see if it'll pull back to $.18.  JC Penney could get 4 X's growth if it rebounds.  Sernova will succeed by commercial investors.  Us retail investors don't affect it much.  We know Sernova likes to pull back.  If it doesn't pull back, I might even buy it back higher.  But the problem is that there's more human trials of proof required before it hits a dollar.  Sertolin is the key ingredient of this procedure.  If Sertolin doesn' t work in humans, the procedure is worthless because they say the harsh sideeffects of anti-rejection drugs are worse than type 1 diabetes itself.  Sertolin will need to be proven in humans before this stock hits a dollar.  The annual trial results pre-sertolin can drive it up to $.50, but then it could be a quick dump scenario to be waiting a year for Sertolin human trials.  I'm confident I can double my money in JC Penney within the next 6 months and come back and buy SVA.V at $.25.  Even if it runs to $.50, I can see it pulling back to $.25 while people wait another year for Sertolin human trials.  I'm a business man.  Showing negative now to drive this stock down so I can buy back lower :).  Bottom line... everyone has selfish motives.  Don't trust anyone on these message boards!  Do your own research and make your decisions. Lol.
Bullboard Posts